Emeis Stock Falls 3.29% After Hitting Technical Resistance
Emeis stock closed the session on Friday, October 10 at €15.00, down 3.29% from the previous day's close of €15.51. This consolidation movement occurs in a challenging market environment, with the CAC 40 itself losing 1.53% on the day. The traded volumes represented 0.42% of the capital, a moderate level indicating activity without excess. Despite this decline, the overall momentum remains significantly positive as the stock still shows an increase of 2.67% over the last seven days, 29.87% over three months, and 160.4% over a year, far exceeding the CAC 40's rise of 4.73% over the same period.
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Technically, the stock has just precisely hit its resistance threshold at €15.51, which exactly corresponds to the previous day's high. The Relative Strength Index (RSI), which measures the speed and magnitude of price movements, stands at 75, a level considered an overbought zone and may signal a temporary exhaustion of the rise. Moreover, the stock is trading above its 50-day moving average (€13.07) and 200-day moving average (€10.75), confirming the medium and long-term upward trend. The MACD, a momentum indicator that captures direction changes, remains positive with a line at 0.54 above its signal line at 0.32, indicating that buying momentum is still present despite the day's correction.
SectorSanté · Etablissements de santé / EHPAD›Etablissements de santé
Context
Period
Period: 9M 2025
Guidance from the release
Croissance organique soutenue (+6,4% à fin septembre 2025, +7,0% au T3), amélioration notable des taux d'occupation, objectifs de cessions dépassés (2,1 Md€) et confirmation des perspectives 2025 et de la trajectoire 2024-2028.
Risks mentioned
Risques et incertitudes liés aux conditions de marché futures pouvant affecter les résultats prévisionnels
Risque de non-réalisation ou de délai des cessions actuellement sécurisées ou en négociation
Impact transitoire des ouvertures récentes sur les taux d'occupation dans certaines zones
Opportunities identified
Croissance démographique des plus de 75 ans (+30% d'ici 10 ans) créant une demande structurelle accrue
Déficit structurel d'offre (déficit attendu de lits sur principaux marchés) offrant une forte visibilité commerciale
Possibilités de capture d'effets prix favorables et d'amélioration de marges opérationnelles
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
